Evaluation of epigenetic methylation biomarkers for the detection of ... - Nature.com
| CRAD-B Stock | SEK 28.65 0.10 0.35% |
About 62% of C Rad's investor base is looking to short. The analysis of current outlook of investing in C Rad AB suggests that many traders are alarmed regarding C Rad's prospects. The current market sentiment, together with C Rad's historical and current headlines, can help investors time the market. In addition, many technical investors use C Rad AB stock news signals to limit their universe of possible portfolio assets.
CRAD-B |
Evaluation of epigenetic methylation biomarkers for the detection of ... Nature.com
Read at news.google.com
 |
C Rad Fundamental Analysis
We analyze C Rad's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of C Rad using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of C Rad based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
C Rad is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
C Rad AB Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with C Rad stock to make a market-neutral strategy. Peer analysis of C Rad could also be used in its relative valuation, which is a method of valuing C Rad by comparing valuation metrics with similar companies.
Peers
C Rad Related Equities
| IZAFE-B | IZafe Group | 5.00 | ||||
| AAC | AAC Clyde | 2.79 | ||||
| SPRINT | Sprint Bioscience | 0.57 | ||||
| MEKO | Mekonomen | 0.46 | ||||
| IDOGEN | Idogen AB | 0.00 | ||||
| IAR-B | IAR Systems | 1.54 | ||||
| LIPUM | Lipum AB | 1.78 | ||||
| KABE-B | KABE Group | 2.65 | ||||
| ALBERT | EEducation Albert | 2.74 | ||||
| CLS-B | Clinical Laserthermia | 9.79 |
Complementary Tools for CRAD-B Stock analysis
When running C Rad's price analysis, check to measure C Rad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy C Rad is operating at the current time. Most of C Rad's value examination focuses on studying past and present price action to predict the probability of C Rad's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move C Rad's price. Additionally, you may evaluate how the addition of C Rad to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |